Pasteur Korea, Sanofi team up to develop new Hepatitis B drugs
By Park Sae-jin
Posted : April 26, 2013, 10:00
Updated : April 26, 2013, 10:00
Although there are medicines and vaccines for the Hepatitis B virus, about 5 percent of the world's population suffer from the virus, IPK officials said.
Those infected with the virus are at a high risk of developing liver cirrhosis and liver cancer, they said.